IMP2 Expression Distinguishes Endometrioid From Serous Endometrial Adenocarcinomas

M.D. Post
In: Yearbook of Pathology and Laboratory Medicine · 2012 · vol. 2012 , pp. 110–112 · doi:10.1016/j.ypat.2011.11.091 · W2327095250
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-09-17 ⓘ

The paper titled "IMP2 Expression Distinguishes Endometrioid From Serous Endometrial Adenocarcinomas" investigates the utility of IMP2 expression as a diagnostic marker to differentiate between endometrioid and serous subtypes of endometrial adenocarcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-11-13T07:27:04.437940+00:00
License: CC0 · commercial use OK